von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty
acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann
Intern Med 1999;130:554-62.))
Mate J, Castanos R, Garcia-Samaniego J, Pajares JM. Does dietary fish oil
maintain the remission of Crohn’s disease: a case control study.
Gastroenterology 1991;100:A228 [abstract].
Kremer JM, Lawrence DA, Petrillow GF, et al. Effects of highdose fish oil on
rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis
Rheum 1995;38:1107-14.
Donadio JV Jr, Bergstrahl EJ, Offord KP, et al. A controlled trial of fish oil
in IgA nephropathy. N Engl J Med 1994;331:1194-9.
Peck LW. Essential fatty acid deficiency in renal failure: can supplements
really help? J Am Diet Assoc 1997;97:5150-3.
Donadio JV Jr, Grande JP, Bergstralh EJ, et al. The long-term outcome of
patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology
Collaborative Group. J Am Soc Nephrol 1999;10:1772-7.
Shahar E, Folsom AR, Melnick SL, et al. Dietary n-3 polyunsaturated fatty
acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in
Communities Study Investigators. N Engl J Med 1994;331:228-33.
Maes M, Christophe A, Bosmans E, et al. In humans, serum polyunsaturated fatty
acid levels predict the response of proinflammatory cytokines to psychological stress.
Biol Psychiatry 2000;47:910-20.
DiGiacoma RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients
with Raynaud’s phenomenon: a double-blind, controlled, prospective study. Am J
Med 1989;86:158-64.
Laugharne JDE, Mellor JE, Peet M. Fatty acids and
schizophrenia.Lipids 1996;31:S163-5.
Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of
omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and
cognitive impairment in schizophrenia. Am J Psychiatry 2001;158:2071-4.
Alexander JW. Immunonutrition: the role of omega-3 fatty acids.Nutr
1998;14:627-33.
Braden LM, Carroll KK. Dietary polyunsaturated fat in relation to mammary
carcinogenesis in rats. Lipids 1986;21(4):285.
O’Connor TP, Roebuck BD, Peterson F, et al. Effect of dietary intake of
fish oil and fish protein on the development of L-azaserine-induced preneoplastic lesions in
the rat pancreas. J Natl Cancer Inst 1985;75:959-62.
Gonzalez MJ. Fish oil, lipid peroxidation and mammary tumor growth. J Am
Coll Nutr 1995;14:325.
Zhu ZR, Mannisto JAS, Pietinene P, et al. Fatty acid composition of breast
adipose tissue in breast cancer patients and patients with benign breast disease. Nutr
Cancer 1995;24:151-60.
Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by
dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr
1997;127:383-93.
Maes M, Smith R, Christophe A, et al. Fatty acid composition in major
depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega
6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord
1996;38:35–46.
Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid
levels in the diet and in red blood cell membranes of depressed patients. J Affect
Disord 1998;48:149–55.
Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels
in red blood cell membranes of depressive patients. Biol Psychiatry
1998;43:315–9.
Maes M, Christophe A, Delanghe J, et al. Lowered omega 3 polyunsaturated fatty
acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry
Res 1999;85:275–91.
Navarro E, Esteve M, Olivé A, et al. Abnormal fatty acid pattern in
rheumatoid arthritis. A rationale for treatment with marine and botanical lipids. J
Rheumatol 2000;27:298–303.
Belluzzi A, Brignola C, Campieri M, et al. Effects of new fish oil derivative
on fatty acid phospholipid-membrane pattern in a group of Crohn’s disease patients.
Dig Dis Sci 1994;39:2589–94.
Burns CP, Halabi S, Clamon GH, et al. Phase I clinical study of fish oil fatty
acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.
Clin Cancer Res 1999;5:3942–7.
Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J
Med 1988;318:549–57.
Malasanos TH, Stacpoole PW. Biological effects of omega-3 fatty acids in
diabetes mellitus. Diabetes Care 1991;14:1160–79.
Schectman G, Kaul S, Kassebah AH. Effect of fish oil concentrate on
lipoprotein composition in NIDDM. Diabetes 1988; 37:1567–73.
Toft I, Bonaa KH, Ingebretsen OC, et al. Effects of n-3 polyunsaturated fatty
acids on glucose homeostasis and blood pressure in essential hypertension. Ann Intern
Med 1995;123:911–8.
Luostarinen R, Wallin R, Wibell L, et al. Vitamin E supplementation
counteracts the fish oil-induced increase of blood glucose in humans. Nutr Res 1995;
15:953–68.
Dunstan DW, Burke V, Mori TA, et al. The independent and combined effects of
aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM.
Diabetes Care 1997; 20:913–21.
Harris WS, Zucker ML, Dujovne CA. Omega-3 fatty acids in type IV
hyperlipidemia: fish oils vs methyl esters. Am J Clin Nutr 1987;45:858 [abstr].
Sheehan JP, Wei IW, Ulchaker M, Tserng KY. Effect of high fiber intake in fish
oil-treated patients with non-insulin-dependent diabetes mellitus Am J Clin Nutr
1997; 66:1183–7.
Adler AJ, Holub BJ. Effect of garlic and fish-oil supplementation on serum
lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr
1997; 65:445–50.